Indo Us Biotech Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015
INDOUS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Indo Us Biotech Limited has informed the exchanges that its trading window will remain closed from Wednesday, 1st April, 2026, until 48 hours after the announcement of its audited financial results for the quarter and year ended 31st March, 2026. This closure is in line with the company's insider trading code under SEBI's Prohibition of Insider Trading Regulations, 2015, and applies to designated persons who cannot trade in the company's shares during this period. The date of the board meeting to approve the Q4 and FY26 audited results will be communicated separately in due course. The letter was signed by Ms. Dimpy Joshi, Company Secretary and Compliance Officer.
This is a routine compliance announcement and does not directly affect shareholders. Investors should note that the company's FY26 audited results are expected to be announced in the coming weeks, which could be a key event for the stock.